This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Antoine Gara

Staff Reporter

Antoine Gara is the Deals Reporter on the Financial Services desk for TheStreet. Prior to joining TheStreet, Antoine was an intern at Bloomberg Businessweek magazine after graduating with a master's degree in business and economic journalism from the Columbia University Graduate School of Journalism. Prior to moving into journalism, Antoine worked as an analyst in the fixed-income operations of Lehman Brothers and Barclays Capital. He is a graduate of Middlebury College.


Antoine Gara
By This Author:
Page 2 of 129
Article

Hedge Fund Reverses Course On Hugely Successful Internet Bank Bet

By Antoine Gara

BofI's net interest margins could fall 40% as the company's opportunity to buy distressed residential mortgage backed securities (RMBS) fades, according to hedge fund Kerrisdale Capital. Meanwhile, BofI's low-cost deposit taking structure may turn from a competitive advantage into a weakness, as short term interest rates rise in coming years.

10:51AM 04/09/14

Article

Why Comcast Can't Use Its Best Argument for Time Warner Cable Deal

By Antoine Gara

Comcast shouldn't kid itself. A more upfront case about why no debt is being used to buy Time Warner Cable may prove Comcast's best defense in Washington

03:43PM 04/08/14

Article

Laclede's $1.6B Alagasco Deal Could Drive Dividend Growth

By Antoine Gara

With Alagasco, Laclede's utility customer base is expected to increase to 1.55 million from about 1.13 million. Laclede will acquire Alagasco for a total consideration of $1.6 billion. The company will also assume $250 million of Alagasco debt.

03:59PM 04/07/14

Article

Mallinckrodt to Buy Questcor: 5 Deals That Blew Up the Short-Sellers

By Antoine Gara

Questcor Pharmaceuticals has been a controversial stock for years, as short selling research firm Citron Research raised concerns about the company's Acthar gel, which is marketed for multiple sclerosis and other autoimmune and inflammatory disorders.

12:07PM 04/07/14

Article

Ken Moelis Wants Your Money, Not Your Input

By Antoine Gara

The best comparison for Moelis & Co.'s shares may be the publicly traded units in private equity firms such as Apollo Global Management, Blackstone Group, Carlyle Group and KKR & Co., and not the investment banking boutique's primary competitors such as Greenhill & Co., Evercore Partners and Lazard , or larger full service firms such as Goldman Sachs and Morgan Stanley.

12:49PM 04/04/14

Article

GrubHub Upsizes Offering Amid Wall Street IPO Feast

By Antoine Gara

Restaurant pick-up and delivery platform GrubHub on Thursday priced its initial public offering at $26 a share, above the $23-to-$25 a share range the company set forth earlier in its IPO process.

06:20PM 04/03/14

Article

KKR, Blackstone, Apollo Are the Best Growth Stocks in Financial Sector

By Antoine Gara

Private-equity firms have significant growth opportunities ahead, particularly in real estate and debt investing, that stock investors are giving little credence to, says Bernstein's analysis.

10:24AM 04/03/14

Article

PG&E Will Fight Criminal Charge in San Bruno Blast

By Antoine Gara

On the heels of civil litigation, the federal charges allege that PG&E willfully violated the Pipeline Safety Act in areas such as record keeping, pipeline integrity management and identification of pipeline threats.

11:01AM 04/02/14

Page 2 of 129

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,262.56 +89.32 0.55%
S&P 500 1,842.98 +12.37 0.68%
NASDAQ 4,034.1610 +11.4670 0.29%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs